Lesabelimab Antibody
Lesabelimab (LDP) is a human IgG1κ monoclonal antibody targeting the CD274 (PD-L1) immune checkpoint protein. By blocking PD-L1's interaction with PD-1, it reactivates T-cell-mediated antitumor immunity, supporting its use in both in vitro cellular assays and in vivo oncology research models.
Product Specifications
Target
PD-1/PD-L1
Clonality
Monoclonal
Conjugation
Unconjugated
Field of Research
Cell Biology, Immunology & Inflammation
Concentration
6.14 mg/mL
Purity
95.00% (May vary between batches)
Storage Conditions
Maintain refrigerated at 2-8°C for up to 2 weeks. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles.
Notes
For research use only.
Available Sizes
More Discoveries
Explore Other Products
Browse additional items from our catalog
abx168885-01 10 µg
Human Aryl Hydrocarbon Receptor Nuclear Translocator 2 (ARNT2) Protein
Sign In for Pricing
View Details 
abx168885-02 50 µg
Human Aryl Hydrocarbon Receptor Nuclear Translocator 2 (ARNT2) Protein
Sign In for Pricing
View Details 
abx168885-03 100 µg
Human Aryl Hydrocarbon Receptor Nuclear Translocator 2 (ARNT2) Protein
Sign In for Pricing
View Details abx168885-04 200 µg
Human Aryl Hydrocarbon Receptor Nuclear Translocator 2 (ARNT2) Protein
Sign In for Pricing
View Details 
abx168885-05 500 µg
Human Aryl Hydrocarbon Receptor Nuclear Translocator 2 (ARNT2) Protein
Sign In for Pricing
View Details